A randomized controlled trial for Chinese medicine prevent health damage caused by fine particulate matter of air pollution

Bingtangtaoyi tea prevent health damage caused by fine particulate matter of air pollution

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000004028

Enrollment

Unknown

Registered

2020-10-22

Start date

2020-11-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Function of Pulmonary

Interventions

Group 2:Oral Placebo

Group 1:Oral Chinese Medicine

Eligibility

Sex/Gender

All

Age

18 Years to 26 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18-26 years. 2. Subjects without smoking history. 3. Subjects in Shijiazhuang in recent one month. 4. The object of informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with cardiovascular and pulmonary diseases, acute infectious diseases and other chronic diseases; 2. Patients with allergic history or family allergic history; 3. Subjects taking other drugs in the past month; 4. Subjects participating in other clinical trials; 5. Those who smoke in the same dormitory.

Design outcomes

Primary

Measure	Time frame
Inflammatory Cell of Sputum;pulmonary function;pulmonary function biomarkers;pulmonary function biomarkers;	—

Secondary

Measure	Time frame
Inflammatory Factor of Sputum;Blood Pressure;Circulating Biomarkers;	—

Countries

China

Contacts

Public ContactLiu Cuiqing

Zhejiang Chinese Medical University

liucuiqing@zcmu.edu.cn+86 571-86633309

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026